A Schedule 13G/A amendment was
Filed with the SEC on · accession 0001167557-26-000206
VRXA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. A Schedule 13G/A amendment was filed regarding Veraxa Biotech Holding AG, indicating a change in a passive institutional holder's beneficial ownership position. The stock moved +0.0% by the first close after the filing.
A Schedule 13G/A amendment was filed regarding Veraxa Biotech Holding AG, indicating a change in a passive institutional holder's beneficial ownership position. The filing directory does not disclose the specific holder, ownership percentage, or share count.
Close before
$1.89
Aug 12, 2026
First close after
+0.00%
$1.89
5 trading days
-1.59%
$1.86
Since filing
-49.74%
$0.95
✦ Ask GOAX AI about this filing — what it means for VRXA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VRXA?
Click hereVRXA filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding Veraxa Biotech Holding AG, indicating a change in a passive institutional holder's beneficial ownership position. The filing directory does not disclose the specific holder, ownership percentage, or share count.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
VRXA closed at $1.89 before the filing and $1.89 on Aug 13, 2026 (+0.00%). Five trading days later: $1.86 (-1.59%).
Get alerts when VRXA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days